{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:11:31Z","timestamp":1790709091047,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T00:00:00Z","timestamp":1465948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA021765"],"award-info":[{"award-number":["P30CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutical Statistics"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>In this paper, we propose a multistage group sequential procedure to design survival trials using historical controls. The formula for the number of events required for historical control trial designs is derived. Furthermore, a transformed information time is proposed for trial monitoring. An example is given to illustrate the application of the proposed methods to survival trial designs using historical controls. Copyright \u00a9 2016 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/pst.1756","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T05:56:55Z","timestamp":1466056615000},"page":"405-411","source":"Crossref","is-referenced-by-count":10,"title":["Survival trial design and monitoring using historical controls"],"prefix":"10.1002","volume":"15","author":[{"given":"Jianrong","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Biostatistics St. Jude Children's Research Hospital  262 Danny Thomas Place Memphis 38105 TN USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Biostatistics St. Jude Children's Research Hospital  262 Danny Thomas Place Memphis 38105 TN USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,15]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"245","article-title":"Randomized versus historical controls: a compromise solution","volume":"9","author":"Pocock S","year":"1976","journal-title":"Proceedings of the International Biometric Conference"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2307\/2530534"},{"key":"e_1_2_9_4_1","first-page":"1089","article-title":"Design of controlled clinical trials: use of historical controls","volume":"66","author":"Gehan EA","year":"1982","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_9_5_1","first-page":"1101","article-title":"Historical controls, data banks, and randomized trials in clinical research: a review","volume":"66","author":"Fleming TR","year":"1982","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780030413"},{"key":"e_1_2_9_7_1","first-page":"430","article-title":"A rational basis for use of historical controls","volume":"8","author":"Gehan EA","year":"1981","journal-title":"Cancer Clinical Trials"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2008.10.013"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.4054"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc6925"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1021"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1293\/tox.21.53"},{"key":"e_1_2_9_13_1","first-page":"431","article-title":"A 5\u2010year period clinical observation on herpes zoster and the incidence of postherpetic neuralgia (2002\u20132006); a comparative analysis with the historical control group of a previous study (1995\u20131999)","volume":"46","author":"Song JY","year":"2008","journal-title":"Korean Journal of Dermatology"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2008.081005"},{"key":"e_1_2_9_15_1","first-page":"175","article-title":"Sample size considerations for non\u2010randomized comparative studies","volume":"33","author":"Makuch RW","year":"1980","journal-title":"Journal of Clinical Epidemiology"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(88)90025-X"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780080203"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2516"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(99)00008-2"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2635"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774510373629"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.2307\/2532094"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/01621459.1995.10476653","article-title":"A class of sequential conditional probability ratio tests","volume":"15","author":"Xiong X","year":"1995","journal-title":"Journal of the American Statistical Association"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1982.10477898"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/70.2.315"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176346505"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/68.1.316"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(81)90007-2"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.2307\/1390786"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780120804"},{"key":"e_1_2_9_31_1","unstructured":"XiongX.SCPRTinfWin: sequential conditional probability ratio tests on information time 2007. Available at:http:\/\/www.stjuderesearch.org\/depts\/biostats\/scprt. [Accessed 2007 February 1]."},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/1541-0420.00072"},{"key":"e_1_2_9_33_1","volume-title":"Counting processes and survival analysis","author":"Fleming TR","year":"1991"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/72.2.365"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2174"}],"container-title":["Pharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpst.1756","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpst.1756","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pst.1756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T03:15:42Z","timestamp":1693710942000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pst.1756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,15]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1002\/pst.1756"],"URL":"https:\/\/doi.org\/10.1002\/pst.1756","archive":["Portico"],"relation":{},"ISSN":["1539-1604","1539-1612"],"issn-type":[{"value":"1539-1604","type":"print"},{"value":"1539-1612","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,15]]}}}